Long-Term Follow-Up of a Pilot Phase II Study with Neoadjuvant Epidoxorubicin, Etoposide and Cisplatin in Gastric Cancer

Oncology ◽  
2004 ◽  
Vol 67 (1) ◽  
pp. 48-53 ◽  
Author(s):  
C. Barone ◽  
A. Cassano ◽  
C. Pozzo ◽  
D. D’Ugo ◽  
G. Schinzari ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Pilot Phase ◽  
Long Term Follow Up

Total estrogen blockade and chemotherapy in high-risk premenopausal early breast cancer (BC): Long-term follow-up of a phase II study.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 537-537
Author(s):  
Francesco Recchia ◽  
Giampiero Candeloro ◽  
Alisia Cesta ◽  
Stefano Necozione ◽  
Silvio Rea ◽  
...  
Keyword(s):  
Breast Cancer ◽  
High Risk ◽  
Early Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Long Term Follow Up

scholarly journals Nimotuzumab Plus Paclitaxel and Cisplatin as a 1st-Line Treatment for Esophageal Cancer: Long Term Follow-up of a Phase II Study

2019 ◽  
Vol 10 (6) ◽  
pp. 1409-1416 ◽  
Author(s):  
Xiaodong Zhang ◽  
Jun Jia ◽  
Ming Lu ◽  
Xicheng Wang ◽  
Jifang Gong ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Line Treatment ◽  
Long Term Follow Up

Maintenance immunotherapy in patients with advanced cancer (AC): Long term follow-up of a phase II study.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e14005-e14005
Author(s):  
Francesco Recchia ◽  
Giampiero Candeloro ◽  
Stefano Necozione ◽  
Massimo Bratta ◽  
Michele Rosselli ◽  
...  
Keyword(s):  
Advanced Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Long Term Follow Up
Sign in / Sign up

Export Citation Format

Share Document